StockWatch
·

ROYAL ORCHID HOTELS LTD. Q1 FY27 Results

ROHLTDQ1 FY27 Results
Filing
Result:Weak· Market: DownMargin squeeze
MetricValueQ4 FY26Q1 FY26
Revenue107.21 Cr5.3%36.1%
Total Income114.70 Cr3.5%38.5%
Expenditure106.53 Cr5.0%56.2%
PBT8.18 Cr9.1%44.0%
Net Profit6.79 Cr17.3%39.3%
OPM23.73%20.87pp1.20pp
NPM5.92%0.99pp7.60pp
EPS2.3419.3%41.4%
View full financials

Consumer/hotel PAT fell 39.3% YoY despite solid revenue and flat-to-better EBITDA margin, as finance costs and depreciation more than tripled/doubled to erase operating gains — a below-par bottom-line print even though the core business held up.

Q1 FY-2027 RESULTS · ROHLTD

Royal Orchid Hotels: consol PAT falls 39% YoY to ₹6.8 Cr as finance costs triple

PAT -39.3% YoY · revenue +36.11% · margins compressing

11 Aug 2026 · 3 min read
Revenue

₹107.21 Cr

+36.11% YoY

PAT (consolidated)

₹6.79 Cr

-39.3% YoY

Net margin

5.92%

-7.6pp YoY

EPS

₹2.34

Royal Orchid Hotels' consolidated PAT fell 39.3% YoY to ₹6.79 Cr (₹6.42 Cr attributable to owners) even as consolidated revenue rose 36.1% YoY to ₹107.21 Cr, against ₹11.19 Cr PAT and ₹78.77 Cr revenue a year ago. Sequentially both lines eased — revenue down 5.3% and PAT down 17.3% from Q4 FY26's ₹113.17 Cr/₹8.22 Cr — a typical post-peak-season pullback for a hotel chain rather than a fresh deterioration. Consolidated EPS was ₹2.34 versus ₹3.99 a year ago. Neither this quarter nor the year-ago quarter carried exceptional items (Q4 FY26 had a ₹2.17 Cr impairment-reversal gain), so the YoY read is on a clean, comparable basis.

The scoreboard

Q1 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q1 FY-2027QoQYoY
Revenue₹107.21 Cr-5.3%+36.1%
Expenses₹106.53 Cr-5%+56.2%
PAT₹6.79 Cr-17.33%-39.3%
Net margin5.92%-1pp-7.6pp
EPS₹2.34-19.3%-41.4%

The profit decline sits entirely below the operating line. EBITDA margin (EBITDA/total income) was effectively flat at 28.7% versus 28.6% a year ago, and EBITDA itself grew 39.1% YoY to ₹32.93 Cr — broadly consistent with management's prior-call expectation of "revenue and EBITDA growth." The squeeze came from finance costs, which more than tripled YoY to ₹13.22 Cr (from ₹3.94 Cr, +235%), and depreciation & amortisation, up 125% to ₹11.53 Cr (from ₹5.13 Cr) — together erasing the EBITDA gain by the time it reaches PBT. That scale of finance-cost increase sits uneasily against management's own framing last quarter of "modest capex... funded by strong internal cash reserves," making it the one clause of prior commentary this print strains against even as top-line and EBITDA growth held up.

305.93316.45326.98337.5348.02313.905-0806-0106-2307-1608-0708-11Q1 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹313.9, down 3.3% over the past month of trading.

₹ Cr
04.919.8214.7213.15Q4 FY25rev ₹87 Cr11.19Q1 FY26rev ₹79 Cr4.29Q2 FY26rev ₹79 Cr9.62Q3 FY26rev ₹113 Cr8.22Q4 FY26rev ₹113 Cr6.79Q1 FY27rev ₹107 Cr
Quarterly consolidated PAT, ₹ Crore
What management guided (4 FY-2026 call)
Management provided limited forward-looking guidance due to current market uncertainties, specifically mentioning the geopolitical situation and rising costs. They are committed to improving performance and are on a growth path, expecting to be in a better position to provide guidance after the first quarter. While rev

This quarter: met

No verifiable consensus PAT estimate for this quarter turned up in search — this is a small-cap with thin formal coverage — though a pre-print MarketsMojo note had already flagged "weak financials and bearish technicals," consistent with the net-margin compression seen here. Standalone PAT fell a milder 21.9% YoY to ₹2.82 Cr on just 9.8% standalone revenue growth (₹52.22 Cr vs ₹47.56 Cr), well below the 36.1% consolidated pace — the topline expansion is concentrated in subsidiaries and managed/revenue-share properties (new launches in Tirupati and Ahmedabad went live during the quarter) rather than the parent's own hotels. Auditors issued a qualified review report on both statements, citing unresolved SEBI/NCLT proceedings over whether erstwhile subsidiary KSDPL should be treated as a subsidiary rather than an associate, with the NCLT matter next heard on 20 August 2026 and the SEBI matter on 13 August 2026. Separately, the board reiterated the record date (28 August 2026) for the FY26 final dividend of ₹2.5/share approved in May; no new dividend accompanied this result. No standalone management press release was available for this filing, so the statement's own notes are the only management commentary on record this quarter.

  • W1

    Finance-cost trajectory — ₹13.22 Cr this quarter (vs ₹3.94 Cr YoY, +235%); watch whether it normalises as new properties season in or stays elevated.

  • W2

    Management said fuller FY27-28 guidance would follow "after the first quarter" per the Q4 FY26 call — watch the Q1 FY27 concall for quantitative targets.

  • W3

    KSDPL SEBI/NCLT proceedings — NCLT hearing 20 August 2026, SEBI matter hearing 13 August 2026 — could affect associate treatment and future consolidated numbers.

Informational and educational content only. Not investment advice.

ROYAL ORCHID HOTELS LTD. (ROHLTD) Q1 FY27 Results — StockWatch